Dysregulated PI3K/AKT signaling is associated with both the pathogenesis and progression of rheumatoid arthritis (RA) and osteoarthritis (OA), suggesting its potential as a therapeutic target for disease-modifying treatments (21). The gene discussed is AKT1; the disease is osteoarthritis.